Small cell lung cancer: Where do we go from here?

DOI Web Site Web Site 被引用文献18件
  • Lauren Averett Byers
    Department of Thoracic/Head and Neck Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas
  • Charles M. Rudin
    Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University Baltimore Maryland

書誌事項

公開日
2014-10-21
権利情報
  • http://onlinelibrary.wiley.com/termsAndConditions#vor
DOI
  • 10.1002/cncr.29098
公開者
Wiley

この論文をさがす

説明

<jats:p>Small cell lung cancer (SCLC) is an aggressive disease that accounts for approximately 14% of all lung cancers. In the United States, approximately 31,000 patients are diagnosed annually with SCLC. Despite numerous clinical trials, including at least 40 phase 3 trials since the 1970s, systemic treatment for patients with SCLC has not changed significantly in the past several decades. Consequently, the 5‐year survival rate remains low at <7% overall, and most patients survive for only 1 year or less after diagnosis. Unlike nonsmall cell lung cancer (NSCLC), in which major advances have been made using targeted therapies, there are still no approved targeted drugs for SCLC. Significant barriers to progress in SCLC include 1) a lack of early detection modalities, 2) limited tumor tissue for translational research (eg, molecular profiling of DNA, RNA, and/or protein alterations) because of small diagnostic biopsies and the rare use of surgical resection in standard treatment, and 3) rapid disease progression with poor understanding of the mechanisms contributing to therapeutic resistance. In this report, the authors review the current state of SCLC treatment, recent advances in current understanding of the underlying disease biology, and opportunities to advance translational research and therapeutic approaches for patients with SCLC. <jats:bold><jats:italic>Cancer</jats:italic> 2015;121:664–672.</jats:bold> © <jats:italic>2014 American Cancer Society</jats:italic>.</jats:p>

収録刊行物

  • Cancer

    Cancer 121 (5), 664-672, 2014-10-21

    Wiley

被引用文献 (18)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ